Journal
CELL METABOLISM
Volume 16, Issue 2, Pages 144-152Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2012.07.004
Keywords
-
Categories
Funding
- Center for Molecular Medicine (CMMC), University of Cologne [TVA1]
- European Union [241592]
- EurOCHIP
- DFG [BR 1492/7-1]
- Federal Ministry of Education and Research [FKZ01GIO845]
Ask authors/readers for more resources
Obesity represents a major risk factor for the development of insulin and leptin resistance, ultimately leading to a pleiotropic spectrum of metabolic alterations. However, resistance to both hormones does not uniformly affect all target cells and intracellular signaling pathways. In contrast, numerous clinical phenotypes arise from selective hormone resistance, leading to inhibition of defined intracellular signaling pathways in some tissues, while in other cell types hormone action is maintained or even overactivated. Here, we review the molecular mechanisms and clinical outcomes resulting from selective insulin and leptin resistance, which should ultimately guide future strategies for the treatment of obesity-associated diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available